NEW YORK (GenomeWeb News) - Illumina said today that it will pay Affymetrix $90 million to settle all ongoing lawsuits between the two companies and that both firms have agreed to a covenant not to sue for use of current and future products.
 
The agreement ends litigation between the companies in the US, Germany, and the UK dating back to 2004.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.